(+/-)-3,4-METHYLENEDIOXYMETHAMPHETAMINE Property

Boiling point:

bp0.4 100-110°

Density 

1.100±0.06 g/cm3(Predicted)

Flash point:

9℃

storage temp. 

2-8°C

pka

10.32±0.10(Predicted)

InChIKey

SHXWCVYOXRDMCX-UHFFFAOYSA-N

EPA Substance Registry System

1,3-Benzodioxole-5-ethanamine, N,.alpha.-dimethyl- (42542-10-9)

Safety

Hazard Codes 

F,T

Risk Statements 

11-23/24/25-39/23/24/25

Safety Statements 

7-16-36/37-45

RIDADR 

UN1230 - class 3 - PG 2 - Methanol, solution

WGK Germany 

1

Hazardous Substances Data

42542-10-9(Hazardous Substances Data)

Toxicity

A novel psychoactive drug chemically related to the hallucinogenic agent MDA, but reported to be non-hallucinogenic. Obtained by direct synthesis, at high doses it is reported to show a stimulant-like effect in animals. Its LD50 is 97 mg/kg, i. p., 49 mg/kg, i.p., 14 mg/kg, i.v., and 22 mg/kg, i.v. in mice, rats, dogs, and monkeys, respectively. At higher doses, MDMA has pressor effects and produces tachycardia, and causes damage to serotonin neurons in both rats and monkeys. The (S)- (1)-enantiomer is more active than the (R)-(?′)-enantiomer and, like amphetamine, the pharmacological effects may be due to a release of endogenous monoamine neurotransmitter, probably serotonin and/or norepinephrine. MDMA is also an inhibitor of monoamine uptake into brain synaptosomes. Symptoms include pronounced mydriasis, with nystagmus and jaw clenching, and nausea also is often reported. This substance produces a feeling of well-being and euphoria and is similar in some respects to MDA, in that it seems to enhance a sense of empathy and emotional openness in users. Toxic reactions would appear to occur as a result of the pressor action, and sympathomimetic effects of the drug. No appropriate therapeutic intervention has been reported. Peripheral adrenergic blocking agents, or chlorpromazine, have been used, however, to prevent death in dogs following a lethal i.v. dose of the chemically related agent MDA.

Hazard and Precautionary Statements (GHS)

Symbol(GHS)

Signal word

Danger

Hazard statements

H225Highly Flammable liquid and vapour

H370Causes damage to organs

Precautionary statements

P210Keep away from heat/sparks/open flames/hot surfaces. — No smoking.

P260Do not breathe dust/fume/gas/mist/vapours/spray.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P301+P310IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.

P311Call a POISON CENTER or doctor/physician.

(+/-)-3,4-METHYLENEDIOXYMETHAMPHETAMINE Chemical Properties,Usage,Production

Uses

3,4-Methylenedioxymethamphetamine (MDMA) is an Entactogen; It is the N-methyl derivative of MDA. The (S)-form of MDMA possesses more potent CNS activity than the (R) form of MDMA.MDMA is controlled substance (hallucinogen).

Definition

ChEBI: A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Metabolic pathway

Four biotransformation pathways of 3,4- (methylenedioxy)methamphetamine (MDMA) in rats are identified as N-demethylation, O-dealkylation, deamination, and conjugation (O-methylation, O- glucuronidation, and/or sulfation). Specific MDMA metabolites identified are 3-hydroxy-4- methoxymethamphetamine, 4-hydroxy-3- methoxymethamphetamine, 3,4- dihydroxymethamphetamine, 4-hydroxy-3- methoxyamphetamine, 3,4- (methylenedioxy)amphetamine (MDA), (4-hydroxy-3- methoxyphenyl)acetone, [3,4- (methylenedioxy)phenyl]acetone, and (3,4- dihydroxyphenyl)acetone. MDMA is metabolized by 10 000 g rat liver supernatant to 4-hydroxy-3- methoxymethamphetamine, 3,4- dihydroxymethamphetamine, MDA, and [3,4- (methylenedioxy)phenyl]acetone. Also, the 10 000 g rat brain supernatant metabolizes MDMA to 4-hydroxy- 3-methoxymethamphetamine, 3,4- dihydroxymethamphetamine, 4-hydroxy-3- methoxyamphetamine, and MDA.